Management ChangeMay 1, 2026, 04:23 PM
Haemonetics Director Charles Dockendorff Not Seeking Re-election
AI Summary
Haemonetics Corporation announced that Charles J. Dockendorff will not stand for re-election at the company's 2026 Annual Meeting of Shareholders. Mr. Dockendorff has served on the Board of Directors since 2014 and is currently a member of the Audit Committee and the Governance and Compliance Committee. He will continue in his roles until the 2026 Annual Meeting, and his decision is not due to any disagreement with the company.
Key Highlights
- Charles J. Dockendorff will not stand for re-election at Haemonetics' 2026 Annual Meeting of Shareholders.
- Mr. Dockendorff has served on the Board of Directors since 2014.
- He currently serves on the Audit Committee and the Governance and Compliance Committee.
- He will continue in his director and committee roles until the 2026 Annual Meeting.
- His decision is not due to any disagreement with Haemonetics Corporation.
Price Impact
More from HAE